CN102727710A - Medicine for treating aplastic anemia - Google Patents
Medicine for treating aplastic anemia Download PDFInfo
- Publication number
- CN102727710A CN102727710A CN2012101762041A CN201210176204A CN102727710A CN 102727710 A CN102727710 A CN 102727710A CN 2012101762041 A CN2012101762041 A CN 2012101762041A CN 201210176204 A CN201210176204 A CN 201210176204A CN 102727710 A CN102727710 A CN 102727710A
- Authority
- CN
- China
- Prior art keywords
- medicine
- aplastic anemia
- herba
- radix
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a medicine for treating aplastic anemia. Raw materials for the medicine comprise, by weight, 4 to 8 of plant soot, 4 to 8 of furnace oil, 4 to 8 of Hypericum japonicum Thunb, 4 to 8 of black alum, 6 to 10 of walnut pulp, 6 to 10 of red date, 6 to 10 of pseudo-ginseng pseudo-ginseng, 1 to 2 of cassia bark, 4 to 8 of dust-doped flour obtained during flour grinding, 1 to 2 of safflower, 1 to 2 of chicken's gizzard membrane, 1 to 4 of epimedium, 1 to 2 of Dioscorea opposite Thunb, 1 to 3 of cassia bark, 1 to 2 of Ranunculus sceleratus and 1 to 2 of red ginseng. A formula for the medicine provided in the invention is simple and practicable; and the medicine has the effects of nourishing and warming kidney-yang, activating the spleen to remove stagnation and promoting blood circulation to remove blood stasis and the advantages of a simple therapeutic method, low cost, no toxicity, no side-effects and no adverse influence on health of patients.
Description
Technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of treatment aplastic anemia medicine.
Background technology:
Aplastic anemia (aplastic anemia, AA, aplastic anemia) is a kind of marrow hematopoiesis function failure disease, mainly shows as hemopoietic hypofunction of marrow, pancytopenia and anemia, hemorrhage, infection syndrome.Main clinical manifestation is anemia, hemorrhage and infection.
1, anemia: pale, weak, dizzy, cardiopalmus is arranged and symptom such as breathe hard.Anxious heavy person is carrying out property more and increases the weight of, and light-duty person is chronic process.
2. infect: the most common with respiratory tract infection, next has digestive tract, urogenital tract and mucocutaneous infections etc.Infection bacteria species is main with gram negative bacilli, staphylococcus and fungus, often merges septicemia.Anxious heavy person has heating more, and body temperature is more than 39oC, and individual patient idiopathy all is among the unmanageable hyperpyrexia to death.Light-duty person's hyperpyrexia is than heavy rare, infects easy to control relatively, more than seldom lasting 1 week.
3. hemorrhage: anxious heavy person all has the different mucocutaneous and visceral hemorrhage of degree.Cutaneous manifestations is petechia or large stretch of ecchymosis, and oral mucosa has bleeding blister, and epistaxis, gum blood, conjunctival hemorrhage etc. are arranged.The visible hematemesis of deep internal organs, spit blood, have blood in stool, hematuria, the women has vaginal hemorrhage, is retinal hemorrhage and intracranial hemorrhage secondly, the latter often jeopardizes patient's life.Light-duty person's bleeding tendency is lighter, is main with mucocutaneous hemorrhage, and visceral hemorrhage is rare.
Aplastic anemia belongs to categories such as the traditional Chinese medical science " asthenia ", " mass formed by blood stasis ".Mainly show as Anemia, hemorrhage and infect, heating is slighter.
Comparatively difficulty is not illustrated, treats yet to Western medicine fully to its cause of disease, and traditional therapy needs periodic transfusions, transfusion and hospitalization, and cure rate is low, and financial burden heavily waits to patient and family members and brought misery and lost the confidence of treating.And the drug price that is used to treat aplastic anemia at present is expensive, medical expense is high, therapeutic effect is undesirable.
Summary of the invention:
The object of the invention is exactly in order to remedy the defective of prior art, a kind of Chinese medicine of treating aplastic anemia to be provided, and it is relief of symptoms fast, improves the adverse effect that primary disease brings to the patient.
The present invention realizes through following technical scheme:
A kind of treatment aplastic anemia medicine, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 4-8, Terra Flava Usta 4-8, Herba Hyperici Japonici 4-8 、 ?vitriol 4-8, Semen Juglandis 6-10, Fructus Jujubae 6-10, Radix Notoginseng 6-10, Cortex Cinnamomi 1-2, Semen Tritici aestivi 4-8, Flos Carthami 1-2, Endothelium Corneum Gigeriae Galli 1-2, Herba Epimedii 1-4, Rhizoma dioscoreae 1-2, Herba Ranunculi Scelerati (Radix Anemones rupicolae) 1-2, Radix Ginseng Rubra 1-2.
A kind of treatment aplastic anemia medicine is characterized in that: Pulvis Fumi Carbonisatus 6, Terra Flava Usta 6, Herba Hyperici Japonici 6 、 ?vitriol 6, Semen Juglandis 8, Fructus Jujubae 8, Radix Notoginseng 8, Cortex Cinnamomi 1, Semen Tritici aestivi 6, Flos Carthami 1, Endothelium Corneum Gigeriae Galli 1, Herba Epimedii 3, Rhizoma dioscoreae 1, Herba Ranunculi Scelerati (Radix Anemones rupicolae) 1, Radix Ginseng Rubra 1.
Every dose of medicine 150g of medicine of the present invention adds water and boil decoction and takes, every day potion, potion is taken at twice.20 days is a course of treatment.
Advantage of the present invention is:
The present invention fills a prescription Radix Ginseng Rubra can strongly invigorating primordial QI, and Cortex Cinnamomi is supporing yang, the Herba Hyperici Japonici detoxifcation, and Radix Notoginseng, Flos Carthami are invigorated blood circulation, short tissue regeneration promoting blood, Pulvis Fumi Carbonisatuss etc. improve blood status, have taken into account the aplastic anemia patient's of different symptoms the patient's condition, and adaptability is good, and remission rate is high.
The specific embodiment:
A kind of treatment aplastic anemia medicine, the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 6, Terra Flava Usta 6, Herba Hyperici Japonici 6 、 ?vitriol 6, Semen Juglandis 8, Fructus Jujubae 8, Radix Notoginseng 8, Cortex Cinnamomi 1, Semen Tritici aestivi 6, Flos Carthami 1, Endothelium Corneum Gigeriae Galli 1, Herba Epimedii 3, Rhizoma dioscoreae 1, Herba Ranunculi Scelerati (Radix Anemones rupicolae) 1, Radix Ginseng Rubra 1.
Every dose of medicine 150g of medicine of the present invention adds water and boil decoction and takes, every day potion, potion is taken at twice.20 days is a course of treatment.
Model case:
Case one:
Huang, man, 55 years old.The patient does not have obvious inducement and finds pale complexion, weak, after local examination in hospital bone is worn, is diagnosed as chronic aplastic anemia, and the petechia appearred in skin afterwards, and oral mucosa has bleeding blister, and phenomenons such as epistaxis, gum blood are arranged.Through taking Drug therapy of the present invention after six months, the color chemical examination is normal.The check routine blood test shows: WBC 4.14 * 10
9/ L HB111g/L PLT35 * 10
9/ L Rc 3.1%.Stable disease.
Case two:
What certain, 20 years old, the man, the jaundice of patient's face, weak all over, hemogram leukocyte 1,000 4, hematochrome 12 grams 2, platelet 40,000 6 being diagnosed as " posthepatitic aplastic anemia " after the check bone is worn, and is interrupted blood transfusion and platelet support, and the state of an illness does not have improvement.Through taking Drug therapy of the present invention less than two months, hemogram just begins to go up, and has broken away from blood transfusion and platelet, and through 3 months time of treatment, the state of an illness is clearly better, and hemogram has also recovered.The check routine blood test shows: WBC 3.94 * 10
9/ L HB114g/L PLT35 * 10
9/ L Rc 3.2%.Stable disease.
Case three:
Lee, the woman, 27 years old, the patient did the bone marrow aspiration inspection because of feeling badly in hospital; Be diagnosed as aplastic anemia, the clinical manifestation pale complexion, feel run-down, extremity skin limb has petechia, and the pale tongue tongue is greasy in vain; Stringy,thready and rapid pulse is unable, take medicine of the present invention after two months its disease take effect, stop the blood transfusion; Thereafter took medicine continuously again back three months, all diseases in the back of taking medicine disappear, and the check routine blood test shows: WBC 3.54 * 10
9/ L HB101g/L PLT29 * 10
9/ L.Stable disease, hale and hearty, resume work.
Case four:
Tight certain, the man, 50 years old, purpura appearred on one's body in the patient; Also some dizziness once in a while, dizzy afterwards sx, and occurred weak, nosebleed; Occurred heating afterwards, having done in hospital that bone marrow examination makes a definite diagnosis is aplastic anemia, through taking Drug therapy of the present invention after 3 months, and patient's nose and tooth hemorrhage controlled; The color chemical examination is normal, has adhered to medication treatment the time more than 1 year, looks the same with the normal person now, and it is all unaffected to do physical labor.
Case five:
The Wang, the woman, 34 years old, because of heart beating, breathe hard, dizzy, inappetence; Lassitude, pale complexion, lip is light red etc., and symptom is gone to the diagnosis and treatment of Chinese medical university, checks through bone marrow aspiration; Be diagnosed as aplastic anemia, invalid through multi-treatment, Nanjing University enriched blood 2 times in every month; After take medicine of the present invention after 3 months the state of an illness take a favorable turn, continuous taking medicine 2 months, the check routine blood test shows: WBC 3.12 * 10
9/ L HB101g/L PLT31 * 10
9/ L.Stable disease.
are existing continues to take medicine.
Claims (2)
1. treat the aplastic anemia medicine for one kind, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 4-8, Terra Flava Usta 4-8, Herba Hyperici Japonici 4-8, ?vitriol 4-8, Semen Juglandis 6-10, Fructus Jujubae 6-10, Radix Notoginseng 6-10, Cortex Cinnamomi 1-2, Semen Tritici aestivi 4-8, Flos Carthami 1-2, Endothelium Corneum Gigeriae Galli 1-2, Herba Epimedii 1-4, Rhizoma dioscoreae 1-2, Herba Ranunculi Scelerati (Radix Anemones rupicolae) 1-2, Radix Ginseng Rubra 1-2.
2. a kind of treatment aplastic anemia medicine according to claim 1 is characterized in that: Pulvis Fumi Carbonisatus 6, Terra Flava Usta 6, Herba Hyperici Japonici 6 、 ?vitriol 6, Semen Juglandis 8, Fructus Jujubae 8, Radix Notoginseng 8, Cortex Cinnamomi 1, Semen Tritici aestivi 6, Flos Carthami 1, Endothelium Corneum Gigeriae Galli 1, Herba Epimedii 3, Rhizoma dioscoreae 1, Herba Ranunculi Scelerati (Radix Anemones rupicolae) 1, Radix Ginseng Rubra 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101762041A CN102727710B (en) | 2012-05-31 | 2012-05-31 | Medicine for treating aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101762041A CN102727710B (en) | 2012-05-31 | 2012-05-31 | Medicine for treating aplastic anemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102727710A true CN102727710A (en) | 2012-10-17 |
| CN102727710B CN102727710B (en) | 2013-11-20 |
Family
ID=46984474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101762041A Expired - Fee Related CN102727710B (en) | 2012-05-31 | 2012-05-31 | Medicine for treating aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727710B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115770282A (en) * | 2022-12-13 | 2023-03-10 | 焦学军 | Pharmaceutical composition for treating aplastic anemia |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1071582A (en) * | 1991-10-12 | 1993-05-05 | 龙孟麟 | Aplastic anemia is converted into leukemia |
| CN1376472A (en) * | 2001-03-27 | 2002-10-30 | 张文志 | Medicine for treating aplastic anemia and its preapring process |
| CN1615922A (en) * | 2003-11-15 | 2005-05-18 | 胡硕泉 | Chinese herbal medicine preparation for treating aplastic anemia |
| CN101628106A (en) * | 2009-07-28 | 2010-01-20 | 王雪梅 | Traditional Chinese medicine bag for treating gynecopathy and treating equipment manufactured by same |
-
2012
- 2012-05-31 CN CN2012101762041A patent/CN102727710B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1071582A (en) * | 1991-10-12 | 1993-05-05 | 龙孟麟 | Aplastic anemia is converted into leukemia |
| CN1376472A (en) * | 2001-03-27 | 2002-10-30 | 张文志 | Medicine for treating aplastic anemia and its preapring process |
| CN1615922A (en) * | 2003-11-15 | 2005-05-18 | 胡硕泉 | Chinese herbal medicine preparation for treating aplastic anemia |
| CN101628106A (en) * | 2009-07-28 | 2010-01-20 | 王雪梅 | Traditional Chinese medicine bag for treating gynecopathy and treating equipment manufactured by same |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115770282A (en) * | 2022-12-13 | 2023-03-10 | 焦学军 | Pharmaceutical composition for treating aplastic anemia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102727710B (en) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN103330835A (en) | Traditional Chinese medicine composition for treating climacteric syndromes | |
| CN102727710B (en) | Medicine for treating aplastic anemia | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN104623379B (en) | A kind of pharmaceutical composition for the treatment of Hand-Food-Mouth Disease | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN102727765B (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
| CN102793845B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN104800491A (en) | Oral solution with superstrong function of improving human immunity | |
| CN103223046B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN105998553A (en) | Traditional Chinese medicine for treating traumatic injury and fracture | |
| CN102552755B (en) | Traditional Chinese medicine composition for treating aplastic anemia | |
| CN102727739B (en) | Traditional Chinese medicine for treating aplastic anemia by nourishing yin | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN104547851B (en) | One treats hypertensive medicine | |
| CN102727748B (en) | Traditional Chinese medicine composition for treating aplastic anemia by nourishing qi and yin | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN101979056A (en) | Traditional Chinese medicament for treating asthma | |
| CN105147971A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis | |
| CN105169106A (en) | Traditional Chinese medicinal preparation for treating hyperplasia of mammary glands | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN102145053A (en) | Traditional Chinese medicine composition with effects of warming channel and promoting circulation of qi | |
| CN102743449A (en) | Powder medicament for treating thrush | |
| CN103417933A (en) | Traditional Chinese medicine for treating acute wind-cold-caused cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131120 Termination date: 20140531 |